Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations.

Nikita StempniewiczJoseph A VassalottiJohn K CuddebackElizabeth L CieminsAmy Storfer-IsserYingying SangKunihiro MatsushitaShoshana H BallewAlex R ChangAndrew S LeveyRobert A BaileyJesse FishmanJosef Coresh

Published in: Diabetes care (2021)

While eGFR testing rates are uniformly high among people with type 2 diabetes, testing rates for uACR are suboptimal and highly variable across and within the organizations examined. Guideline-recommended uACR testing should increase detection of CKD.

Keyphrases

chronic kidney disease
primary care
healthcare
small cell lung cancer
end stage renal disease
tyrosine kinase
quantum dots